Gen Li

Analysis of over 330,000 Phesi trial protocols shows predicting future enrollment performance by extrapolating data is flawed.

A trial’s success depends on enrolling the planned number of patients in the shortest possible time frame. Such thinking can insight a limited focus on obtaining and analyzing all investigator site enrollment data - as if that would solve all problems pertaining to site enrollment performance, writes Gen Li, President of Phesi.